• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺动脉高压中肺动脉平滑肌细胞内缺氧诱导ATP生成从糖酵解向线粒体呼吸转变的证据

Evidence for Hypoxia-Induced Shift in ATP Production from Glycolysis to Mitochondrial Respiration in Pulmonary Artery Smooth Muscle Cells in Pulmonary Arterial Hypertension.

作者信息

Akagi Satoshi, Nakamura Kazufumi, Kondo Megumi, Hirohata Satoshi, Udono Heiichiro, Nishida Mikako, Saito Yukihiro, Yoshida Masashi, Miyoshi Toru, Ito Hiroshi

机构信息

Department of Cardiovascular Medicine, Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama 700-8558, Japan.

Department of Medical Technology, Graduate School of Health Sciences, Okayama University, Okayama 700-8558, Japan.

出版信息

J Clin Med. 2023 Jul 31;12(15):5028. doi: 10.3390/jcm12155028.

DOI:10.3390/jcm12155028
PMID:37568430
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10419513/
Abstract

BACKGROUND

The metabolic state of pulmonary artery smooth muscle cells (PASMCs) from patients with pulmonary arterial hypertension (PAH) is not well understood. In this study, we examined the balance between glycolysis and mitochondrial respiration in non-PAH-PASMCs and PAH-PASMCs under normoxia and hypoxia.

METHODS

We investigated the enzymes involved in glycolysis and mitochondrial respiration, and studied the two major energy-yielding pathways (glycolysis and mitochondrial respiration) by measuring extracellular acidification rate (ECAR) and cellular oxygen consumption rate (OCR) using the Seahorse extracellular flux technology.

RESULTS

Under both normoxia and hypoxia, the mRNA and protein levels of pyruvate dehydrogenase kinase 1 and pyruvate dehydrogenase were increased in PAH-PASMCs compared with non-PAH-PASMCs. The mRNA and protein levels of lactate dehydrogenase, as well as the intracellular lactate concentration, were also increased in PAH-PASMCs compared with non-PAH-PASMCs under normoxia. However, these were not significantly increased in PAH-PASMCs compared with non-PAH-PASMCs under hypoxia. Under normoxia, ATP production was significantly lower in PAH-PASMCs (59 ± 5 pmol/min) than in non-PAH-PASMCs (70 ± 10 pmol/min). On the other hand, ATP production was significantly higher in PAH-PASMCs (31 ± 5 pmol/min) than in non-PAH-PASMCs (14 ± 3 pmol/min) under hypoxia.

CONCLUSIONS

There is an underlying change in the metabolic strategy to generate ATP production under the challenge of hypoxia.

摘要

背景

肺动脉高压(PAH)患者肺动脉平滑肌细胞(PASMCs)的代谢状态尚未完全明确。在本研究中,我们检测了常氧和低氧条件下非PAH-PASMCs和PAH-PASMCs中糖酵解与线粒体呼吸之间的平衡。

方法

我们研究了参与糖酵解和线粒体呼吸的酶,并使用海马细胞外流量技术通过测量细胞外酸化率(ECAR)和细胞耗氧率(OCR)来研究两条主要的能量产生途径(糖酵解和线粒体呼吸)。

结果

与非PAH-PASMCs相比,在常氧和低氧条件下,PAH-PASMCs中丙酮酸脱氢酶激酶1和丙酮酸脱氢酶的mRNA和蛋白水平均升高。与非PAH-PASMCs相比,在常氧条件下PAH-PASMCs中乳酸脱氢酶的mRNA和蛋白水平以及细胞内乳酸浓度也升高。然而,与非PAH-PASMCs相比,在低氧条件下PAH-PASMCs中的这些指标并未显著升高。在常氧条件下,PAH-PASMCs的ATP产生量(59±5 pmol/分钟)显著低于非PAH-PASMCs(70±10 pmol/分钟)。另一方面,在低氧条件下,PAH-PASMCs的ATP产生量(31±5 pmol/分钟)显著高于非PAH-PASMCs(14±3 pmol/分钟)。

结论

在低氧挑战下,产生ATP的代谢策略存在潜在变化。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/7fb3fede1368/jcm-12-05028-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/619a1b3cd695/jcm-12-05028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/2d4d1a4d638f/jcm-12-05028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/311caaf774db/jcm-12-05028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/45eec64add81/jcm-12-05028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/4906bee45a8f/jcm-12-05028-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/7fb3fede1368/jcm-12-05028-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/619a1b3cd695/jcm-12-05028-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/2d4d1a4d638f/jcm-12-05028-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/311caaf774db/jcm-12-05028-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/45eec64add81/jcm-12-05028-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/4906bee45a8f/jcm-12-05028-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3cd9/10419513/7fb3fede1368/jcm-12-05028-g006.jpg

相似文献

1
Evidence for Hypoxia-Induced Shift in ATP Production from Glycolysis to Mitochondrial Respiration in Pulmonary Artery Smooth Muscle Cells in Pulmonary Arterial Hypertension.肺动脉高压中肺动脉平滑肌细胞内缺氧诱导ATP生成从糖酵解向线粒体呼吸转变的证据
J Clin Med. 2023 Jul 31;12(15):5028. doi: 10.3390/jcm12155028.
2
Adenylate Kinase 4-A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1α Signaling Pathways.腺苷酸激酶 4-A 通过 Akt 和 HIF-1α 信号通路调控人肺动脉平滑肌细胞的增殖和代谢重编程。
Int J Mol Sci. 2021 Sep 26;22(19):10371. doi: 10.3390/ijms221910371.
3
Identification of Celastramycin as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension.鉴定鬼臼霉素为肺动脉高压的新型治疗药物。
Circ Res. 2019 Jul 19;125(3):309-327. doi: 10.1161/CIRCRESAHA.119.315229. Epub 2019 Jun 14.
4
[Effect of opening of mitochondrial ATP-sensitive K(+) channels on the expression of hypoxia inducible factor-1alpha and cell proliferation in pulmonary arterial smooth muscle cells of rats].[线粒体ATP敏感性钾通道开放对大鼠肺动脉平滑肌细胞缺氧诱导因子-1α表达及细胞增殖的影响]
Sheng Li Xue Bao. 2007 Apr 25;59(2):157-62.
5
miR-143 and miR-145 promote hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells through regulating ABCA1 expression.miR-143 和 miR-145 通过调节 ABCA1 表达促进低氧诱导的肺动脉平滑肌细胞增殖和迁移。
Cardiovasc Pathol. 2018 Nov-Dec;37:15-25. doi: 10.1016/j.carpath.2018.08.003. Epub 2018 Aug 23.
6
Cannabidiol attenuates pulmonary arterial hypertension by improving vascular smooth muscle cells mitochondrial function.大麻二酚通过改善血管平滑肌细胞线粒体功能来减轻肺动脉高压。
Theranostics. 2021 Mar 11;11(11):5267-5278. doi: 10.7150/thno.55571. eCollection 2021.
7
alpha1A-adrenoceptor is involved in norepinephrine-induced proliferation of pulmonary artery smooth muscle cells via CaMKII signaling.α1A-肾上腺素能受体通过 CaMKII 信号通路参与去甲肾上腺素诱导的肺动脉平滑肌细胞增殖。
J Cell Biochem. 2019 Jun;120(6):9345-9355. doi: 10.1002/jcb.28210. Epub 2018 Dec 5.
8
An abnormal mitochondrial-hypoxia inducible factor-1alpha-Kv channel pathway disrupts oxygen sensing and triggers pulmonary arterial hypertension in fawn hooded rats: similarities to human pulmonary arterial hypertension.异常的线粒体-缺氧诱导因子-1α-Kv通道途径破坏氧感知并引发淡黄褐毛大鼠的肺动脉高压:与人类肺动脉高压的相似性
Circulation. 2006 Jun 6;113(22):2630-41. doi: 10.1161/CIRCULATIONAHA.105.609008. Epub 2006 May 30.
9
Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress.低氧通过线粒体片段化介导的内质网应激诱导肺动脉平滑肌功能障碍。
Aging (Albany NY). 2020 Nov 18;12(23):23684-23697. doi: 10.18632/aging.103892.
10
TRIM32 inhibits the proliferation and migration of pulmonary artery smooth muscle cells through the inactivation of PI3K/Akt pathway in pulmonary arterial hypertension.TRIM32 通过抑制肺动脉平滑肌细胞中 PI3K/Akt 通路的活化抑制肺动脉高压中的细胞增殖和迁移。
J Bioenerg Biomembr. 2021 Jun;53(3):309-320. doi: 10.1007/s10863-021-09880-w. Epub 2021 Mar 10.

引用本文的文献

1
Physicochemical and Biological Modifications in Mesenchymal Stem Cells-Derived Conditioned Media Under Hypoxic Preconditioning: Impact on Oxidative Stress and Nanoparticle Stability.缺氧预处理下间充质干细胞来源的条件培养基中的物理化学和生物学修饰:对氧化应激和纳米颗粒稳定性的影响。
Life (Basel). 2025 Apr 26;15(5):702. doi: 10.3390/life15050702.
2
The role of lactate metabolism and lactylation in pulmonary arterial hypertension.乳酸代谢和乳酸化在肺动脉高压中的作用。
Respir Res. 2025 Mar 12;26(1):99. doi: 10.1186/s12931-025-03163-3.
3
Glycolysis modulation: New therapeutic strategies to improve pulmonary hypertension (Review).

本文引用的文献

1
Adenylate Kinase 4-A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1α Signaling Pathways.腺苷酸激酶 4-A 通过 Akt 和 HIF-1α 信号通路调控人肺动脉平滑肌细胞的增殖和代谢重编程。
Int J Mol Sci. 2021 Sep 26;22(19):10371. doi: 10.3390/ijms221910371.
2
Lessons from Cancer Metabolism for Pulmonary Arterial Hypertension and Fibrosis.从癌症代谢角度探讨肺动脉高压与肺纤维化。
Am J Respir Cell Mol Biol. 2021 Aug;65(2):134-145. doi: 10.1165/rcmb.2020-0550TR.
3
Metabolism in Pulmonary Hypertension.
糖酵解调节:改善肺动脉高压的新治疗策略(综述)。
Int J Mol Med. 2024 Dec;54(6). doi: 10.3892/ijmm.2024.5439. Epub 2024 Oct 18.
4
Expression and regulation of HIF-1a in hypoxic pulmonary hypertension: Focus on pathological mechanism and Pharmacological Treatment.低氧性肺动脉高压中 HIF-1a 的表达与调控:关注病理机制与药物治疗。
Int J Med Sci. 2024 Jan 1;21(1):45-60. doi: 10.7150/ijms.88216. eCollection 2024.
肺动脉高压中的代谢
Annu Rev Physiol. 2021 Feb 10;83:551-576. doi: 10.1146/annurev-physiol-031620-123956.
4
Hypoxia-inducible factor signaling in pulmonary hypertension.低氧诱导因子信号通路与肺动脉高压
J Clin Invest. 2020 Nov 2;130(11):5638-5651. doi: 10.1172/JCI137558.
5
We need to talk about the Warburg effect.我们需要谈谈瓦伯格效应。
Nat Metab. 2020 Feb;2(2):127-129. doi: 10.1038/s42255-020-0172-2.
6
Role of Hypoxia-Inducible Factors in Regulating Right Ventricular Function and Remodeling during Chronic Hypoxia-induced Pulmonary Hypertension.低氧诱导因子在慢性低氧性肺动脉高压诱导的右心室功能和重构中的作用。
Am J Respir Cell Mol Biol. 2020 Nov;63(5):652-664. doi: 10.1165/rcmb.2020-0023OC.
7
Mitochondrial Metabolism as a Target for Cancer Therapy.线粒体代谢作为癌症治疗的靶点。
Cell Metab. 2020 Sep 1;32(3):341-352. doi: 10.1016/j.cmet.2020.06.019. Epub 2020 Jul 14.
8
Current and future treatments of pulmonary arterial hypertension.肺动脉高压的当前及未来治疗方法。
Br J Pharmacol. 2021 Jan;178(1):6-30. doi: 10.1111/bph.15016. Epub 2020 Mar 23.
9
PFKFB3-mediated endothelial glycolysis promotes pulmonary hypertension.PFKFB3 介导的内皮细胞糖酵解促进肺动脉高压。
Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13394-13403. doi: 10.1073/pnas.1821401116. Epub 2019 Jun 18.
10
Thin Air, Thick Vessels: Historical and Current Perspectives on Hypoxic Pulmonary Hypertension.稀薄空气,增厚血管:低氧性肺动脉高压的历史与现状
Front Med (Lausanne). 2019 May 1;6:93. doi: 10.3389/fmed.2019.00093. eCollection 2019.